Visit the Canopy Growth Corp Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
Canopy Growth and Delta 9 applaud Manitoba Cannabis plan
The decision by the Government of Manitoba to allow for private retail distribution of cannabis while ensuring that public safety and health concerns are the focal points of its cannabis policies is a strong and welcomed approach. As responsible existing cannabis businesses, Delta 9 and Canopy Growth plan to work collaboratively within the proposed Manitoba framework to bring locally produced products as well as the best variety from across the country to future cannabis consumers throughout the province.
The Companies submitted a collaborative expression of interest in July, 2017 outlining their proposed participation in the Manitoba market including production and distribution functions with both companies pursuing privately owned and operated retail.
As provinces continue to roll out distribution and retail strategies we are starting to gain a clearer understanding of our operational needs leading into next year. Manitoba has signalled an openness to private retail operations, and as responsible private companies already meeting the strict regulations for the production and sale of medical cannabis across the country, we believe our track record positions us well to satisfy the government’s objectives while meeting the needs of Manitoba consumers. We are proud to partner with a respected, responsible local Manitoba company in Delta 9 to bring our offering forward.
Mark Zekulin, President, Canopy Growth
While working together in Manitoba, Delta 9 has also entered into a distribution arrangement with Canopy Growth that will allow Delta 9 to expand its retail presence outside the province as Canopy pursues distribution deals similar to the agreement it entered with the Province of New Brunswick in September, 2017, to bring the highest quality and best variety of products to consumers across the country.
“As a cannabis producer headquartered in Winnipeg, our team is very pleased at the prospect of expanding our operations to include physical locations in addition to our existing e-commerce solution,” said Delta 9 Co-Founder and CEO John Arbuthnot,.
Here’s to Future Growth.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis company, offering distinct brands and curated cannabis varieties in dried, oil and capsule forms. Through its wholly‑owned subsidiaries, Canopy Growth operates numerous state-of-the-art production facilities with over half a million square feet of GMP-certified indoor and greenhouse production capacity, all to an unparalleled level of quality assurance procedures and testing. Canopy Growth has established partnerships with leading sector names in Canada and abroad, with interests and operations spanning four continents. The Company is proudly dedicated to educating healthcare practitioners, providing consistent access to high quality cannabis products, conducting robust clinical research, and furthering the public’s understanding of cannabis. For more information visit www.canopygrowth.com.
About Delta 9
Delta 9 Cannabis Inc., through its wholly-owned subsidiary, Delta 9 Bio-tech, is a licensed producer of medical marijuana pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The company operates an 80,000 square foot, expandable, state-of-the-art production facility in Winnipeg, Manitoba, Canada. For more information please visit Delta9.ca.
For fact-based information on Canopy Growth Corp, view the company’s sponsored Investor Dashboard.
Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.